Objective:
To explore the role of telehealth in the diagnosis and treatment of dry eye disease (DED).
Approach:
- Patient Care Insights: Discusses patient delays in seeking care and the potential of telehealth platforms for managing DED.
- Telehealth Implementation: Describes a direct-to-consumer telehealth platform for DED that includes an online symptom questionnaire and home delivery of treatment.
- Assessment Tools: Highlights the importance of validated questionnaires like the Ocular Surface Disease Index (OSDI) for remote assessments.
- Hybrid Care Model: Proposes a hybrid model combining telehealth visits with in-person exams for comprehensive care.
Key Findings:
- Approximately 16 million Americans are affected by dry eye disease.
- Many patients delay seeking care, with significant numbers experiencing symptoms for years.
- Teleoptometry is effective for managing diagnosed patients and monitoring treatment compliance.
- A complete dry eye workup requires in-person exams and specialized equipment.
Interpretation:
Telehealth can enhance access to care and follow-up for DED but is not a substitute for comprehensive in-person evaluations.
Limitations:
- Telehealth platforms may have poor image quality, impacting assessment accuracy.
- Conditions mimicking dry eye require in-person examinations for proper diagnosis.
Conclusion:
A hybrid model of care is suggested, starting with telehealth for symptom review followed by in-person exams.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.